Website Logo
Website Logo
Spotlight
COVID-19Sickle Cell Disease
Clinical
View MoreADHDAllergyArterial DiseaseCardiologyDermatologyDiabetesGastroenterologyGeriatric MedicineInfectious DiseaseInflammationNeurologyPsychiatryPulmonologyRheumatology
Video Series
InsightsNews NetworkPeers & PerspectivesPost Conference Perspectives
News
Media
Medical World News
Peer Exchange
Podcasts
Videos
Webinars
Conferences
Conference Coverage
Conference Listing
PartnersCME/CE
Resources
Exclusive Content
Interactive Tools
Live Events
Press Release
Publications
Sponsored
Subscribe
Spotlight
  • COVID-19
  • Sickle Cell Disease
ClinicalSee All >
  • ADHD
  • Allergy
  • Arterial Disease
  • Cardiology
  • Dermatology
  • Diabetes
  • Gastroenterology
  • Geriatric Medicine
  • Infectious Disease
  • Inflammation
  • Neurology
  • Psychiatry
  • Pulmonology
  • Rheumatology
Video Series
  • Insights
  • News Network
  • Peers & Perspectives
  • Post Conference Perspectives
hcplive podcasts
  • About Us
  • Advertise
  • Editorial
  • Contact Us
  • Do Not Sell My Information
  • Privacy
  • Terms & Conditions
  • MJHLS Brand Logo

© 2022 MJH Life Sciences™ and HCPLive - Clinical news for connected physicians. All rights reserved.

Early Initiation With LAIs to Optimally Manage Schizophrenia

EP. 1: Overview of Schizophrenia

May 21st 2020

EP. 2: Challenges for the Treatment of Schizophrenia

May 21st 2020

EP. 3: Schizophrenia: Relapse Prevention and Adverse Effects

May 21st 2020

EP. 4: Schizophrenia: Treatment Adherence

May 21st 2020

EP. 5: Psychosocial Treatments for the Management of Schizophrenia

May 21st 2020

EP. 6: Use of Oral Therapy for the Management of Schizophrenia

May 21st 2020

EP. 7: Guidelines for the Treatment of Schizophrenia

May 21st 2020

EP. 8: Switching From Oral Therapy to Long-Acting Injectables

May 21st 2020

EP. 9: Initiating LAI Therapy for the Treatment of Schizophrenia

May 21st 2020

EP. 10: Management of Schizophrenia and Available LAIs

May 21st 2020

Latest News

Jennifer Green, MD: Outcomes, Impact of SGLT2i, GLP-1 RA Combination Therapy

Joshua J. Joseph, MD: Managing CV Risk Factors in Patients with Type 2 Diabetes

Antirituximab Antibodies Detected in Patients with Pemphigus

View More News